INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Feb 24, 2022
Document Date
Feb 22, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
Van Plew Daniel P